The EC1-GLuc-liposome effectivly targeted ErbB2-overexpressing ovarian cancer cells for bioluminescence imaging in vitro and in vivo, and also proved to be effective in targeted DDS. This evidence concerns the gene ERBB2 and ovarian carcinoma.